在具有结构性SLC7A5变体的基尿患者中,蛋白质体活性和疾病结局
Miroslaw Bik-Multanowski1,2, Sylwia Bobis-Wozowicz3, Marcin Piejko4
1Institute of Human Genetics, University Hospital, LMU Munich, Munich, Germany. miroslaw.bikmultanowski@med.uni-muenchen.de.
Scientific reports
|December 12, 2025
概括
基尿症的治疗结果各不相同. 一种特定的SLC7A5基因变异 (rs113883650) 可能会改善患有基尿症的儿童的智力发育,尽管超重的风险增加.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
背景情况:
- 基尿症 (PKU) 治疗依赖于饮食来控制高氨血症.
- 在PKU患者的临床结果有所不同,可能是由于氨运输的差异.
- 氨基酸载体LAT1影响氨酸的运输和mTORC1/蛋白质体通路.
研究的目的:
- 为了研究一种特定的SLC7A5基因变异 (rs113883650) 在基uria中的临床和细胞效应.
- 探索这种变异如何影响氨代谢和智力发展.
- 阐明与变种相关的细胞机制,包括LAT1丰度和信号通路.
主要方法:
- 评估了患有基尿症的儿童的身体和智力发展.
- 使用诱导的多能干干细胞利用超氨血症的细胞模型.
- 进行了转录基因和蛋白质基因分析,以检查LAT1丰富度,蛋白质体基因表达和FOXO信号通路.
主要成果:
- rs113883650多态的携带者表现出明显更好的智力发展.
- 这些携带者更容易超重.
- 细胞分析显示LAT1丰富度增加和蛋白质体基因和FOXO信号通路在载体中的表达减少.
结论:
- rs113883650多态状态可能是监测患有基尿症的儿童的相关因素.
- 这种遗传变异可能会影响治疗策略和患者的治疗结果.
- 这些发现也可能对其他涉及LAT1的疾病产生影响,例如某些癌症.
相关概念视频
Inborn Errors of Metabolism
681
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
681
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
Overview of Protein Metabolism
3.5K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
3.5K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Allosteric Proteins-ATCase
6.4K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.4K


